BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 26, 2012
View Archived Issues
Ablynx and Merck Serono advance ALX-0751 into preclinical development
Read More
Benefits seen with rhLAMAN in patients with alpha-mannosidosis
Read More
Mundipharma launches Flutiform in Germany
Read More
CHMP recommends VEGF Trap-Eye in wet AMD
Read More
CHMP gives positive opinion on Cialis in new indication
Read More
Kyorin files NDA in Japan for asthma drug
Read More
Chinese group synthesizes new SGLT2 inhibitors
Read More
Roche describes new dual dopamine/serotonin receptor ligands
Read More
Novel gamma-secretase modulators disclosed by Roche
Read More
ProteoTech presents novel agents for Parkinson's disease
Read More
Researchers at Repligen divulge new HDAC inhibitors
Read More
Zalicus presents new agents for pain
Read More
Herb-based lotion relieves symptoms of atopic dermatitis
Read More
Melatonin identified as a marker of brain serotonin metabolism
Read More
First patient enrolled in Isofol Medical's phase I/II Modufolin trial
Read More
Northwest Biotherapeutics prepares for phase I/II DCVax-Direct study
Read More
Galderma and NovaBay enroll first patients in phase IIb NVC-422 trial
Read More
Novartis researchers identify novel orexin receptor antagonists for sleep disorders
Read More
Researchers evaluate CPP-109 in Tourette's syndrome
Read More
Valeant Pharmaceuticals acquires Visudyne from QLT
Read More
Novartis reports results from phase III RELAX-AHF study
Read More
Novel PLK1 inhibitors show potent antiproliferative activity in vitro
Read More
Novartis obtains positive CHMP opinions for Galvus and Eucreas
Read More
Daiichi Sankyo completes phase III study of prasugrel in ACS
Read More
Avastin recommended for approval of recurrent, platinum-sensitive ovarian cancer in Europe
Read More
EMA committee recommends approval of enzyme-based debriding agent for burn care
Read More
Janssen Pharma seeks approval in Japan for paliperidone extended-release injection
Read More
Votubia recommended for approval in Europe
Read More